Get In Touch With Us

Interested in learning more about our company, our product REOLYSIN®, our clinical trials or partnership opportunities?

Calgary, Alberta (Head office)

210, 1167 Kensington Crescent NW
Calgary, Alberta T2N 1X7


Tel: (403) 670-7377

La Jolla, California

920 Kline St.
La Jolla, CA 92037

Investor Relations

Michael Moore
Vice President Investor Relations and Corporate Communications


Tel: (403) 670-7377 Ext. 2

Business Development

Andrew de Guttadauro
Global Head of Business Development, President, Oncolytics Biotech (U.S.) Inc.

We'd Love To Hear From You